Rankings
Pricing
Log In
Free Trial
US-listed companies
Reneo Pharmaceuticals, Inc.
Reneo Pharmaceuticals, Inc.
RPHM
Market cap
$60.63M
P/E ratio
Add to your list
Add to your list
Back to summarized table
B
M
K
USD
Annual
Quarterly
Download CSV
Income statement
Balance sheet
Cash flow
Dec 31,
2021
Dec 31,
2022
Cash and cash equivalents
125
20
Short-term investments
23
81
Prepaid expenses and other current assets
6
5
Total current assets
154
106
Property and equipment, net
0
0
Right-of-use assets
-
1
Other non-current assets
0
0
Total assets
154
108
Accounts payable
2
2
Accrued expenses
4
5
Operating Lease, Liability, Current
-
0
Total current liabilities
6
7
Deferred rent
0
-
Operating Lease, Liability, Noncurrent
-
1
Performance award
0
0
Total liabilities
7
8
Common Stock, Value, Issued
0
0
Additional paid-in capital
232
237
Accumulated deficit
-85
-137
Accumulated other comprehensive (loss) income
0
-0
Total stockholders' equity
147
100
Total liabilities and stockholders' equity
154
108